Literature DB >> 3229837

Early osteoarthritis in young sportsmen with severe anterolateral instability of the knee.

G P Graham1, J A Fairclough.   

Abstract

In a retrospective study of patients presenting with symptoms of knee instability, 16 patients were discovered who had developed severe chondromalacia or osteoarthritis of the femoral condyles. All of the patients gave a history of a previous severe knee injury occurring in their teenage years and all had continued to play competitive sport. Ten of the group had subsequent meniscal injuries requiring surgery. In nine of the group previous arthroscopic or open joint procedures had demonstrated normal femoral joint cartilage. There was no difference in the degree of degeneration in those who had had a meniscectomy as compared with those who had not had meniscal damage. It is concluded that severe anterolateral instability is a cause of early degenerative joint disease in young athletes even in the absence of meniscal damage and that they should be strongly advised against participating in active sport until the joint has been stabilized.

Entities:  

Mesh:

Year:  1988        PMID: 3229837     DOI: 10.1016/0020-1383(88)90037-x

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  3 in total

1.  Changes in biochemical parameters after anterior cruciate ligament injury.

Authors:  H Higuchi; K Shirakura; M Kimura; M Terauchi; T Shinozaki; H Watanabe; K Takagishi
Journal:  Int Orthop       Date:  2005-12-07       Impact factor: 3.075

2.  Posttraumatic anterior cruciate ligament insufficiency as a cause of osteoarthritis in a knee joint.

Authors:  P Kannus; M Järvinen
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes.

Authors:  A von Porat; E M Roos; H Roos
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.